Hadasit Bio (CE) Stock Quote HSITF - Stock Price, News, Charts, Message Board, Trades

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

Home
Investing
Stocks
USA
USOTC
Hadasit Bio Holdings Ltd (CE) (HSITF) Quote

Hadasit Bio Holdings Ltd (CE) (HSITF)

0.13

0.00

( 0.00% )

Updated: 20:00:00

Delayed by 15 minutes

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.13

Bid

0.00

Ask

0.00

Volume

-

0.00 Day's Range 0.00

0.0003 52 Week Range 0.27

Market Cap

Previous Close

0.13

Open

-

Last Trade

Last Trade Time

-

Financial Volume

-

VWAP

-

Average Volume (3m)

200

Shares Outstanding

11,088,522

Dividend Yield

-

PE Ratio

-0.05

Earnings Per Share (EPS)

-2.81

Revenue

-

Net Profit

-31.21M

Sector

Medicinal Chems,botanicl Pds

Industry

Investors, Nec

Website

www.hbl.co.il

Headquarters

Jerusalem, Isr

Founded

2005

Hadasit Bio Holdings Ltd (CE) is listed in the Medicinal Chems,botanicl Pds sector of the OTCMarkets with ticker HSITF. The last closing price for Hadasit Bio (CE) was $0.13. Over the last year, Hadasit Bio (CE) shares have traded in a share price range of $ 0.0003 to $ 0.27.

Hadasit Bio (CE) currently has 11,088,522 shares outstanding. The market capitalization of Hadasit Bio (CE) is $1.44 million. Hadasit Bio (CE) has a price to earnings ratio (PE ratio) of -0.05.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0.13	0.13	0.13	200	0.13	CS
12	0	0	0.13	0.13	0.13	200	0.13	CS
26	0	0	0.13	0.13	0.13	200	0.13	CS
52	0.1297	43233.3333333	0.0003	0.27	0.0003	355	0.18203521	CS
156	-2.02	-93.9534883721	2.15	2.18	0.0003	2651	1.78266262	CS
260	-1.1875	-90.1328273245	1.3175	3.2456	0.0003	2397	1.96143709	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAUDCollective Audience Inc	$ 0.7348 (88.41%)	135.23M
DCPHDeciphera Pharmaceuticals Inc	$ 25.21 (72.08%)	39.05M
HWHHWH International Inc	$ 2.5401 (39.57%)	22.17M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 9.675 (35.31%)	59.39M
TSLTT Rex 2X Long Tesla Daily Target ETF	$ 13.23 (35.28%)	10.16M
CLVRClever Leaves Holdings Inc	$ 1.5702 (-61.80%)	604.91k
ADXNAddex Therapeutics Ltd	$ 8.35 (-48.14%)	116.17k
TSDDGraniteShares ETF Trust GraniteShares	$ 16.14 (-35.18%)	1.08M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	$ 25.51 (-35.04%)	5.29M
MFImF International Ltd	$ 1.542 (-33.82%)	2.36M
TSLATesla Inc	$ 197.866 (17.57%)	150.91M
CAUDCollective Audience Inc	$ 0.7348 (88.41%)	135.23M
SINTSiNtx Technologies Inc	$ 0.0527 (30.45%)	133.86M
SOFISoFi Technologies Inc	$ 7.085 (-9.97%)	109.83M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	$ 9.675 (35.31%)	59.39M

goodolboy

goodolboy 12 years ago

"The Company was established for the purpose of promoting and commercializing the intellectual property and R&D capabilities generated by Hadassah."

So, it is established to pump stuff it doesn't own, making it a publicly traded paid promoter. Interesting.

goodolboy

goodolboy 12 years ago

That seems odd to say the least. Trade other company's stock to raise money for their own company? First, how did they acquire the stock to begin with, and is there a balance sheet to view assets/holdings? And, where did they get the cash to purchase those shares, or what agreements were in place for a stock exchange?

Very strange indeed.

Entangled Proton

Entangled Proton 12 years ago

I found a contact number for the U.S. When get the time I'm going to use it. I have some very basic questions like why does 1 stock end with a "Y" and one with a "S".

Why is only one used in the PR's ? ect.

Pythia

Pythia 12 years ago

Do you have any thoughts about HSITF?

Entangled Proton

Entangled Proton 12 years ago

Shares Outstanding 87,523,450 a/o Jul 14, 2011

Entangled Proton

Entangled Proton 12 years ago

Hadasit Bio-Holdings (TASE: HDST, OTC: HADSY) a publicly traded portfolio of biotech companies, all based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that the recruitment of 13 patients for the Enlivex Phase I/II clinical trial has been completed.

http://ih.advfn.com/p.php?pid=nmona&article=50851106&symbol=HADSY

Entangled Proton

Entangled Proton 12 years ago

Business Description Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) in order to allow public participation in the highly promising field of biotechnology. It serves as a precedent in biotech financing - for the first time, public investment is allowed to participate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").

Entangled Proton

Entangled Proton 12 years ago

Not quite sure how this is going to work, but Hadasit will be using several US and foriegn stocks to raise money for research.

Pythia

Pythia 13 years ago

Well to post new finds on A PENNY FLIPPER

http://investorshub.advfn.com/boards/board.aspx?board_id=20062

hurtszz

hurtszz 13 years ago

Hadasit Bio (CE)

Delayed Upgrade Clock

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions